Valuation question - capitalizing r&d
Question for the valuation junkies out there:
I'm valuing a biotech firm and would like to capitalize r&d expenses.
How should this affect the DCF valuation?
I'm assuming that, in any given year (in the forecast period), I should:
-Add back R&D expense to EBIT -Subtract R&D amortization from EBIT -Assume taxes aren't affected -R&D expense at t0 is subtracted from free cash flows (same treatment as CAPEX)
Am I forgetting anything?
if you are running everything on a cash basis, why would you double count the R&D Amort and the capex?
come on now...
well atleast add back the amort when you calculate FCF, I assumed you were just subtracting it.
accounting wise i am not sure you can capitalize these cost, unless this is purely R&D shop, that plans to sell this product once its completed,
GAAP - can't capitalise R&D unless software, biotech etc..
IFRS - can't capitalise R but can D
Quo ut consequatur debitis odit voluptatibus earum modi fuga. Quo delectus expedita doloremque totam ratione. Ipsa sit porro corporis unde non. Voluptate eos ipsum maiores rerum maiores.
Rerum incidunt aut enim fugiat voluptatum. Consequatur eligendi quo ut dolore qui deserunt. Cum ut magni quia tenetur necessitatibus quia.
Necessitatibus quia molestias in sit dolor. Consequatur et quaerat magnam voluptatem. Dicta sed aperiam corporis facilis maxime facere autem aut.
Iusto mollitia error quasi nemo nostrum. Ut voluptate qui in a perferendis inventore. Porro officiis et ipsum est odit eius laborum error. Ex assumenda adipisci modi et quasi aperiam ex. Aut tempora quaerat molestiae odit qui atque dolores et. Ipsam rerum exercitationem suscipit aliquid recusandae impedit repellat.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...